EP3142661
METHOD FOR SUPPRESSING GLUCAGON SECRETION OF AN SGLT2 INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.5.2015EP published:
6.10.2021EP application number:
15726257.7
EPO information:
European Patent Register
Max expiry date:
13.5.2035
Title:
METHOD FOR SUPPRESSING GLUCAGON SECRETION OF AN SGLT2 INHIBITOR
Timeline
Today
14.5.2015EP application
6.10.2021EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
HIRSHBERG, BoazAddress:
Gaithersburg MD 20878, US
Name:
IQBAL, NayyarAddress:
Gaithersburg MD 20878, US
Priority
Number:
201461994222 PDate:
16.5.2014Country:
US
Number:
201462011084 PDate:
12.6.2014Country:
US
Classification
Categories:
A61K 31/40, A61K 31/403, A61K 31/4985, A61K 31/522, A61K 31/70, A61K 31/7042, A61P 3/10, A61K 38/28, A61K 31/155